3,672 results on '"ATOPIC dermatitis"'
Search Results
2. Evolving Trends in Pediatric Allergic Diseases: A Cross-Sectional Study Over 20 Years in the Central Black Sea Region of Turkey.
- Author
-
Karadag, Sefika Ilknur Kokcu, Sariaydin, Burak, Sariaydin, Ayşegül, and Sancak, Recep
- Subjects
- *
POLICY sciences , *CROSS-sectional method , *ATOPIC dermatitis , *MEDICAL protocols , *DRUG allergy , *HEALTH policy , *ALLERGIES , *BRONCHITIS , *DESCRIPTIVE statistics , *FOOD allergy , *QUANTITATIVE research , *CHI-squared test , *SURVEYS , *ALLERGIC rhinitis , *SEASONAL variations of diseases , *COMPARATIVE studies , *DATA analysis software , *ASTHMA , *NONPARAMETRIC statistics , *CHILDREN - Abstract
Background: In the past two decades, the prevalence of asthma, eczema, and allergic rhinitis has increased among school-aged children in the Central Black Sea region of Turkey. This increase is consistent with national and international data, reflecting the impact and temporal changes of allergic diseases on the community. A similar increasing trend is also observed worldwide. This study aims to contribute to the development of health policies related to allergic diseases among Turkish children in the Central Black Sea region. Materials and Methods: This study compares the results of two cross-sectional surveys conducted in schools in and around Samsun, Turkey, between the years 2006 and 2022, examining changes in the prevalence of specific allergic diseases such as asthma, allergic rhinitis, and atopic eczema. Utilizing the Turkish translation of the International Study of Asthma and Allergies in Childhood protocol, the research encompassed a total of 1,310 and 3,219 children, respectively. Results: In the recent study conducted in 2022, the prevalence of asthma and allergic bronchitis diagnosed by physicians was found to be 10.5% and 4.6%, respectively. In addition, the prevalence of allergic rhinitis was determined to be 3.1% and the prevalence of atopic dermatitis was 2.5%. Moreover, previously unidentified rates of food allergy were determined to be 2.5%, and drug allergy was found to be 2.4%. Furthermore, a comparison with a cross-sectional study conducted in the same region 20 years ago revealed a statistically significant increase in the prevalence of physician-diagnosed asthma and allergic bronchitis (with P-values of 0.0375 and 0.0107, respectively). Discussion: The findings of this study suggest a similar trend of increasing prevalence of allergic diseases when compared with similar studies at national and global levels. Consistent with trends identified in the international literature, Turkey is also affected by the rising prevalence of allergic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Using a survey, analyzing the current situation of allergic March in elementary and junior high school students of oyama and tochigi cities, Japan.
- Author
-
Abid, Hamid, Ando, Yusuke, Miyamoto, Manabu, and Yoshihara, Shigemi
- Subjects
ALLERGIC rhinitis ,ATOPIC dermatitis ,FOOD allergy ,ALLERGIES ,JUNIOR high school students - Abstract
Over the past few decades, allergic diseases have become more prevalent and impact around 20% of the global population. There is clinical significance of allergic march as it places a burden on the quality of life of children and their families. To assess the current situation of allergy conditions experienced by children attending elementary and junior high schools in Oyama and Tochigi cities, Japan. A letter was sent to parents informing them about an opt-in online survey concerning children's allergies along with a weblink and a QR code. A video explained the survey process and informed parents that their replies could not be retracted. Parents who had watched the explanation video and answered yes to participating were considered to have provided consent for the survey. A total of 2038 valid replies were gathered. Allergic Rhinitis was the most commonly diagnosed allergy, followed by Asthma, Food Allergy, and Atopic Dermatitis. Around 70% of the children were affected by the allergies, of whom half had been affected by multiple allergies. Most children affected by Atopic Dermatitis, Food Allergy or Asthma were affected by other allergies. Atopic Dermatitis and Food Allergy were mostly diagnosed before Asthma and Allergic Rhinitis. Children who are diagnosed with either Atopic Dermatitis or a Food Allergy will likely be affected by other allergies later in life. Allergic march perpetuated an earlier peak diagnosis incident rate for allergic rhinitis. Allergic Rhinitis can occur independently from other allergies compared to Atopic Dermatitis, Food Allergy and Asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis.
- Author
-
Danto, Spencer I., Tsamandouras, Nikolaos, Reddy, Padma, Gilbert, Steven A., Mancuso, Jessica Y., Page, Karen, Beebe, Jean S., Peeva, Elena, and Vincent, Michael S.
- Subjects
- *
ATOPIC dermatitis , *THERAPEUTICS , *ALLERGIES , *INTERLEUKIN-33 , *SINUSITIS - Abstract
PF-06817024 is a humanized antibody against interleukin-33 that has the potential to inhibit type 2 inflammation. An exploratory analysis of the pharmacodynamics and clinical effects of single and repeat doses of PF-06817024 was assessed in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and patients with moderate-to-severe atopic dermatitis (AD), respectively, as part of a Phase 1, first-in-human study. Rhinosinusitis symptoms were improved, and nasal polyps were decreased in size following treatment with PF-06817024 in patients with CRSwNP. In patients with AD, PF-06817024, in aggregate, reduced disease severity and improved symptoms, as demonstrated by greater percentage decrease from baseline in Eczema Area and Severity Index (EASI) scores and reduced pruritus numerical rating scores, compared with placebo. The efficacy in AD appeared to be bimodal with a sub-group of participants exhibiting high levels of improvement (EASI75 and EASI90) for a sustained period of time after dosing. In patients with CRSwNP, a consistent trend of decrease in eosinophil levels was observed in the PF-06817024 group, compared with placebo. Further research would be needed to confirm the clinical benefit and safety of PF-06817024 as a treatment for allergic diseases. Trial registration ClinicalTrials.gov, NCT02743871. Registered 15 April 2016, https://clinicaltrials.gov/study/NCT02743871?term=NCT02743871&rank=1. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Maternal allergy‐preventive diet index, offspring infant diet diversity, and childhood allergic diseases.
- Author
-
Venter, Carina, Pickett‐Nairne, Kaci, Leung, Donald, Fleischer, David, O'Mahony, Liam, Glueck, Deborah H., and Dabelea, Dana
- Subjects
- *
ELECTRONIC health records , *ALLERGIES , *ATOPIC dermatitis , *ALLERGIC rhinitis , *FOOD allergy , *WHEEZE - Abstract
Background Methods Results Conclusions Studies of childhood diet diversity and allergic disease have not examined additional associations with an offspring allergy‐linked maternal diet index during pregnancy. We studied both associations in a pre‐birth cohort.Offspring allergic disease diagnoses were obtained from electronic medical records. Maternal and infant diet were self‐reported. Adjusted parametric Weibull time‐to‐event models assessed associations between maternal diet index, infant diet diversity and time to development of allergic rhinitis, atopic dermatitis, asthma, wheeze, IgE‐mediated food allergy, and a combined outcome of any allergic disease except for wheeze.Infant diet diversity at 1 year was associated with the risk of the combined outcome between 1 and 4 years of age (p = .002). While both maternal diet index and infant diet diversity at 1 year were associated with the risk of the combined outcome between 1 and 4 years of age (both p < .05), infant diet diversity at 1 year did not modify the association between maternal diet index and the risk of the combined outcome between 1 and 4 years of age (p = .5). The group with the lowest risk of the combined allergy outcome had higher maternal diet index and higher infant diet diversity.The novel finding that both maternal diet index during pregnancy and infant diet diversity at 12 months are associated with the risk of a combined allergic disease outcome points to two targets for preventive interventions: maternal diet index scores during pregnancy and offspring diet diversity during infancy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Phase 1 Safety and Pharmacokinetics Study of TAVO101, an Anti‐Human Thymic Stromal Lymphopoietin Antibody for the Treatment of Allergic Inflammatory Conditions.
- Author
-
Han, Chao, Fung, Isa, Zhang, Di, Jin, Ying, Chen, Peng, Tam, Susan, Chiu, Mark L., and Fung, Man‐Cheong
- Subjects
- *
THYMIC stromal lymphopoietin , *IMMUNE response , *ATOPIC dermatitis , *ALLERGIES , *TRANSGENIC mice - Abstract
TAVO101 is a humanized anti‐human thymic stromal lymphopoietin (TSLP) monoclonal antibody under clinical development for the treatment of atopic dermatitis (AD) and other allergic inflammatory conditions. The crystallizable fragment region of the antibody was engineered for half‐life extension and attenuated effector functions. This Phase 1, double‐blinded, randomized, placebo‐controlled study assessed the safety, tolerability, pharmacokinetics, and immunogenicity of TAVO101 in healthy adult subjects in seven ascending dose cohorts. Subjects received a single intravenous administration of TAVO101 or placebo with a 195‐day follow‐up. TAVO101 was safe and well tolerated. The incidences and severities of treatment‐emergent adverse events were mostly mild and comparable between the active and placebo groups, with no trends of dose relationship. There were no severe adverse events, deaths, or treatment‐related withdrawals. TAVO101 exhibited a linear pharmacokinetic profile, low clearance, and a median elimination half‐life of 67 days in healthy subjects. All TAVO101‐treated subjects tested negative for anti‐drug antibodies. To support development in AD, TAVO101 was studied in an oxazolone‐induced AD model in
hTSLP transgenic mice and demonstrated efficacy. This long‐acting anti‐TSLP antibody has the potential for stronger and sustained allergic inflammatory disease control. The results from this study warranted further clinical development of TAVO101 in patients. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
7. Causal Effects of Asthma on Upper Airway Diseases and Allergic Diseases: A Two-Sample Mendelian Randomization.
- Author
-
Zhang, Zengxiao, Li, Gongfei, Zhou, Shizhe, Wang, Minghui, Yu, Longgang, and Jiang, Yan
- Subjects
- *
ALLERGIC conjunctivitis , *GENOME-wide association studies , *ALLERGIES , *ALLERGIC rhinitis , *ATOPIC dermatitis - Abstract
Asthma is associated with upper airway diseases and allergic diseases; however, the causal effects need to be investigated further. Thus, we performed this two-sample Mendelian randomization (MR) analysis to explore and measure the causal effects of asthma on allergic rhinitis (AR), vasomotor rhinitis (VMR), allergic conjunctivitis (AC), atopic dermatitis (AD), and allergic urticaria (AU).Introduction: The data for asthma, AR, VMR, AC, AD, and AU were obtained from large-scale genome-wide association studies summarized recently. We defined single-nucleotide polymorphisms satisfying the MR assumptions as instrumental variables. Inverse-variance weighted (IVW) approach under random-effects was applied as the dominant method for causal estimation. The weighted median approach, MR-Egger regression analysis, MR pleiotropy residual sum and outlier test, and leave-one-out sensitivity analysis were performed as sensitivity analysis. Horizontal pleiotropy was measured using MR-Egger regression analysis. Significant causal effects were attempted for replication and meta-analysis.Methods: We revealed that asthma had causal effects on AR (IVW, odds ratio [OR] = 1.93; 95% confidence interval [CI], 1.74−2.14;Results: p < 0.001), VMR (IVW, OR = 1.40; 95% CI, 1.15−1.71;p < 0.001), AC (IVW, OR = 1.65; 95% CI, 1.49−1.82;p < 0.001), and AD (IVW, OR = 2.13; 95% CI, 1.82−2.49;p < 0.001). No causal effect of asthma on AU was observed. Sensitivity analysis further assured the robustness of these results. The evaluation of the replication stage and meta-analysis further confirmed the causal effect of asthma on AR (IVW OR = 1.81, 95% CI 1.62–2.02,p < 0.001), AC (IVW OR = 1.44, 95% CI 1.11–1.87,p < 0.001), and AD (IVW OR = 1.85, 95% CI 1.42–2.41,p < 0.001). We revealed and quantified the causal effects of asthma on AR, VMR, AC, and AD. These findings can provide powerful causal evidence of asthma on upper airway diseases and allergic diseases, suggesting that the treatment of asthma should be a preventive and therapeutic strategy for AR, VMR, AC, and AD. [ABSTRACT FROM AUTHOR]Conclusions: - Published
- 2024
- Full Text
- View/download PDF
8. Serum TARC and SCCA2 Levels In Infantile Atopic Dermatitis: Associations with Atopy and Severity.
- Author
-
BERBER, Ilkay Bahar BALABAN, KOKSAL, Zeynep GULEC, YILMAZ, Mustafa, OMURLU, Imran KURT, UYSAL, Pinar, and ERGE, Duygu
- Subjects
- *
ATOPIC dermatitis , *CHEMOKINES , *SQUAMOUS cell carcinoma , *ALLERGENS , *THYMUS , *RESEARCH funding , *IMMUNOGLOBULINS , *SEVERITY of illness index , *FOOD allergy , *ALLERGIES , *INFANT care , *TUMOR antigens , *BIOMARKERS , *SKIN tests , *SENSITIVITY & specificity (Statistics) , *EVALUATION - Abstract
Objective: Atopic dermatitis [AD] is a common chronic inflammatory skin disease. Although numerous indicators have been investigated, reliable biomarkers are still needed to objectively measure the severity of AD. We aimed to evaluate serum thymus and activation regulated chemokine (TARC) and squamous cell carcinoma antigen (SCCA2) levels in infants with AD, and the relationship between these biomarkers and atopy and severity. Materials and Methods: Forty-two children with AD and 42 healthy controls were included in the study. The severity was evaluated via SCORAD at the baseline, 1 month, and 3 months. Food-specific Ig E (sIgE) and/or skin prick tests were performed to determine food sensitivity in the AD group. Serum TARC and SCCA2, complete blood count parameters, and serum total IgE were measured in the AD group. Results: Analysis showed that 54.8% of the AD group were mild to moderate and 45.2% were severe. Food sensitivity was present in 42.9% of the patients with AD. There was no difference between AD and control groups in terms of serum TARC and SCCA2 levels (p>0.05). Serum TARC levels were higher in the AD group with food sensitivity (p=0.033). A high degree of positive correlation was determined between food sIgE values and serum TARC levels in the AD group (r=0.517, p<0.001). A significant positive correlation was observed between serum TARC and SCCA2 levels in the AD and control groups (r=0.600; p<0.01, and r=0.830, p<0.001, respectively). Conclusion: Serum TARC levels were high in AD patients with food sensitivity. Serum TARC and food sIgE values were positively correlated. Serum TARC levels may be associated with food sensitivity in patients with AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Association Between Three Atopic Triad and Retinal Vein Occlusion Risk: A Nationwide Population-Based Study.
- Author
-
Kim, Seongho, Kim, Bo Hee, Han, Kyungdo, Kong, Mingui, and Song, Su Jeong
- Subjects
- *
RETINAL vein occlusion , *ALLERGIC rhinitis , *ALLERGIES , *NATIONAL health insurance , *ATOPIC dermatitis , *BRONCHIAL spasm , *RETINAL artery - Abstract
To evaluate the association between three allergic diseases (allergic dermatitis, allergic rhinitis, and asthma) and the development of retinal vein occlusion (RVO), a major retinal disease that causes visual impairment. This study used data obtained from the Korean National Health Insurance Claims database between 2009 and 2018. The association between the three atopic triads (allergic dermatitis, allergic rhinitis, and asthma) and the occurrence of sight-threatening RVO, as determined by diagnostic and treatment codes, were analyzed. Multivariate adjusted Cox regression analysis was used to determine the hazard ratios (HRs) and 95% confidence intervals for RVO development in the presence of allergic disease. In this population-based study, 2,160,195 (54.6%) individuals were male, 1,794,968 (45.4%) were female, and 620,938 (15.7%) were diagnosed with allergic diseases. Patients with either asthma or allergic rhinitis had a greater risk of RVO (adjusted hazard ratio (aHR) = 1.101, 95% confidence interval [CI] = 1.029–1.178 for asthma; aHR = 1.181, 95% CI = 1.147–1.215 for allergic rhinitis) compared to those without asthma or allergic rhinitis; however, patients with atopic dermatitis did not show a significant association with RVO (aHR = 1.071, 95% CI = 0.889–1.290), after adjusting for other risk factors. Our study revealed that allergic rhinitis, asthma, and coexisting multiple allergic conditions were associated with an increased risk of RVO. Thus, it may be advisable to suggest an ophthalmological examination for patients with allergies due to the increased possibility of the occurrence of retinal vascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Dupilumab: Mechanism of action, clinical, and translational science.
- Author
-
McCann, Marc R., Kosloski, Matthew P., Xu, Christine, Davis, John D., and Kamal, Mohamed A.
- Subjects
- *
EOSINOPHILIC esophagitis , *NASAL polyps , *ATOPIC dermatitis , *ALLERGIES , *DISEASE prevalence - Abstract
Allergic disease prevalence has increased globally with the subset of type 2 inflammatory diseases playing a substantial role. Type 2 inflammatory diseases may differ in clinical presentation, but they exhibit shared pathophysiology that is targeted by the unique pharmacology of dupilumab. Dupilumab binds to the interleukin (IL)‐4 receptor alpha subunit (IL‐4Rα) that blocks IL‐4 and IL‐13 signaling, two key drivers of type 2 inflammation. Herein, we review the mechanism of action and pharmacology of dupilumab, and the clinical evidence that led to the regulatory approvals of dupilumab for the treatment of numerous type 2 inflammatory diseases: atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Contact allergy to neomycin in consecutively patch tested Danish eczema patients from 2000 to 2023: A cross‐sectional study.
- Author
-
Kursawe Larsen, Christoffer, Jensen, Mikkel Bak, and Schwensen, Jakob F. B.
- Subjects
- *
NEOMYCIN , *ATOPIC dermatitis , *ALLERGIES , *CROSS-sectional method , *PRODUCT elimination - Abstract
Background Objectives Methods Results Conclusion Neomycin is an aminoglycoside antibiotic that may cause contact allergy. It was withdrawn as a medicine for human use in Denmark in October 2009 but is still found in some vaccines.To identify time trends in contact allergy to neomycin in the period from 2000 to 2023.A cross‐section study of patients ≥18 years consecutively patch‐tested with neomycin sulfate (20% in pet.) at Gentofte Hospital, Denmark, during the period 2000–2023 was conducted.The overall prevalence of contact allergy to neomycin was 1.4%. The prevalence was significantly lower in the period ‘2010–2023’ (1.2%) than in ‘2000–2009’ (1.8%) (p < 0.005). Contact allergy to neomycin was significantly positively associated with facial dermatitis and age >40 years, and significantly negatively associated with occupational dermatitis and hand dermatitis. No changes in sex, occupational dermatitis, atopic dermatitis, hand dermatitis, leg dermatitis, facial dermatitis, or age > 40/≤40 (the MOAHLFA‐index) were identified when comparing neomycin contact allergic‐patients in the two periods ‘2010–2023’ and ‘2001–2009’.Neomycin is a rare cause of contact allergy in Denmark with a significantly lower prevalence following its withdrawal as a medicinal product for human use in Denmark in 2009. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Vitamin D and allergic diseases.
- Author
-
Panyu Zhang, Qingxiu Xu, and Rongfei Zhu
- Subjects
VITAMIN D ,ALLERGIES ,ALLERGIC rhinitis ,ATOPIC dermatitis ,DIETARY supplements - Abstract
Institute of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China In recent years, the relationship between vitamin D and allergic diseases has received widespread attention. As a fat-soluble vitamin, vitamin D plays a crucial role in regulating the immune system and may influence the onset and progression of diseases such as atopic dermatitis, allergic rhinitis, and asthma. To understand the underlying mechanisms, we have summarized the current research on the association between vitamin D and allergic diseases. We also discuss the impact of vitamin D on the immune system and its role in the course of allergic diseases, particularly focusing on how vitamin D supplementation affects the treatment outcomes of these conditions. We aim to provide a theoretical basis and practical guidance for optimizing the management and treatment of allergic diseases by modulating vitamin D levels. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Decoding the role of DNA methylation in allergic diseases: from pathogenesis to therapy.
- Author
-
Han, Ruiming, Zhu, Dongdong, Sha, Jichao, Zhao, Boning, Jin, Peng, and Meng, Cuida
- Subjects
- *
ALLERGIES , *DNA methylation , *IMMUNOGLOBULIN E , *FOOD allergy , *ALLERGIC rhinitis , *ATOPIC dermatitis - Abstract
Allergic diseases, characterized by a broad spectrum of clinical manifestations and symptoms, encompass a significant category of IgE-mediated atopic disorders, including asthma, allergic rhinitis, atopic dermatitis, and food allergies. These complex conditions arise from the intricate interplay between genetic and environmental factors and are known to contribute to socioeconomic burdens globally. Recent advancements in the study of allergic diseases have illuminated the crucial role of DNA methylation (DNAm) in their pathogenesis. This review explores the factors influencing DNAm in allergic diseases and delves into their mechanisms, offering valuable perspectives for clinicians. Understanding these epigenetic modifications aims to lay the groundwork for improved early prevention strategies. Moreover, our analysis of DNAm mechanisms in these conditions seeks to enhance diagnostic and therapeutic approaches, paving the way for more effective management of allergic diseases in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Zinc Deficiency and Zinc Supplementation in Allergic Diseases.
- Author
-
Maywald, Martina and Rink, Lothar
- Subjects
- *
FOOD allergy , *ALLERGIES , *ATOPIC dermatitis , *ALLERGIC rhinitis , *DIETARY fiber , *ZINC - Abstract
In recent decades, it has become clear that allergic diseases are on the rise in both Western and developing countries. The exact reason for the increase in prevalence has not been conclusively clarified yet. Multidimensional approaches are suspected in which diet and nutrition seem to play a particularly important role. Allergic diseases are characterized by a hyper-reactive immune system to usually harmless allergens, leading to chronic inflammatory diseases comprising respiratory diseases like asthma and allergic rhinitis (AR), allergic skin diseases like atopic dermatitis (AD), and food allergies. There is evidence that diet can have a positive or negative influence on both the development and severity of allergic diseases. In particular, the intake of the essential trace element zinc plays a very important role in modulating the immune response, which was first demonstrated around 60 years ago. The most prevalent type I allergies are mainly based on altered immunoglobulin (Ig)E and T helper (Th)2 cytokine production, leading to type 2 inflammation. This immune status can also be observed during zinc deficiency and can be positively influenced by zinc supplementation. The underlying immunological mechanisms are very complex and multidimensional. Since zinc supplements vary in dose and bioavailability, and clinical trials often differ in design and structure, different results can be observed. Therefore, different results are not surprising. However, the current literature suggests a link between zinc deficiency and the development of allergies, and shows positive effects of zinc supplementation on modulating the immune system and reducing allergic symptoms, which are discussed in more detail in this review. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Systematic review of the association between short‐chain fatty acids and allergic diseases.
- Author
-
Sasaki, Mari, Suaini, Noor H. A., Afghani, Jamie, Heye, Kristina N., O'Mahony, Liam, Venter, Carina, Lauener, Roger, Frei, Remo, and Roduit, Caroline
- Subjects
- *
WHEEZE , *SHORT-chain fatty acids , *ALLERGIES , *FOOD allergy , *ATOPIC dermatitis , *CHILD development - Abstract
We performed a systematic review to investigate the current evidence on the association between allergic diseases and short chain fatty acids (SCFAs), which are microbially produced and suggested as one mechanism on how gut microbiome affects the risk of allergic diseases. Medline, Embase and Web of Science were searched from data inception until September 2022. We identified 37 papers, of which 17 investigated prenatal or early childhood SCFAs and the development of allergic diseases in childhood, and 20 assessed SCFAs in patients with pre‐existing allergic diseases. Study design, study populations, outcome definition, analysis method and reporting of the results varied between papers. Overall, there was some evidence showing that the three main SCFAs (acetate, propionate and butyrate) in the first few years of life had a protective effect against allergic diseases, especially for atopic dermatitis, wheeze or asthma and IgE‐mediated food allergy in childhood. The association between each SCFA and allergic disease appeared to be different by disease and the age of assessment. Further research that can determine the potentially timing specific effect of each SCFA will be useful to investigate how SCFAs can be used in treatment or in prevention against allergic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Maternal gestational diabetes mellitus and risk of allergic diseases in offspring.
- Author
-
Hsu, Min-Che, Lin, Chien-Heng, and Lin, Ming-Chih
- Subjects
GESTATIONAL diabetes ,ALLERGIES ,ALLERGIC rhinitis ,PREGNANT women ,JUVENILE diseases ,URTICARIA - Abstract
Gestational diabetes mellitus has been linked to inflammation, immune dysregulation in offspring, and changes in the microbiota. It may have long-term implications for the health of children. The aim of this study was to determine if gestational diabetes mellitus increases the risk of allergic diseases in offspring. The data source was the National Health Insurance Research Database (NHIRD) of Taiwan. The pairing of mothers and children was established by connecting the NHIRD with the Taiwan Maternal and Child Health Database. First-time pregnant mothers between 2004 and 2019 were enrolled. The GDM group consisted of 22,741 cases. The control group was selected from individuals without GDM matched by maternal age, neonatal gender, and neonatal birthdate at a ratio of 1–4. The primary endpoint was the incidence of childhood allergic diseases, such as asthma, allergic rhinitis, atopic dermatitis, and urticaria. The secondary endpoint was the risk associated with the development of allergic diseases in offspring, considering the presence or absence of insulin therapy. The development of allergic rhinitis, atopic dermatitis, and urticaria were found to be significantly associated with GDM. However, no significant association was observed between GDM and asthma. GDM control without insulin was associated with an increased risk of developing allergic rhinitis, urticaria, and atopic dermatitis. However, in the group receiving insulin treatment, there was no significant elevation in the risk of any allergic diseases. GDM may elevate the risk of certain atopic diseases in offspring, such as allergic rhinitis, atopic dermatitis, and urticaria. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases.
- Author
-
Antosz, Katarzyna, Batko, Joanna, Błażejewska, Marta, Gawor, Antoni, Sleziak, Jakub, and Gomułka, Krzysztof
- Subjects
ATOPIC dermatitis ,THERAPEUTICS ,ALLERGIES ,INTERLEUKIN-5 ,EOSINOPHILS ,URTICARIA - Abstract
Interleukin-5 functions as a B-cell differentiation factor, but more importantly, in the context of this review, it plays a variety of roles in eosinophil biology, including eosinophil differentiation and maturation in the bone marrow, and facilitates eosinophil migration to tissue sites, usually in the context of an allergic reaction. Given the availability of selective anti-IL-5 drugs such as mepolizumab and reslizumab, as well as the IL-5 receptor antagonist benralizumab, it is worth investigating whether they could be used in some cases of allergic disease. Asthma has a well-documented involvement of IL-5 in its pathophysiology and has clear benefits in the case of anti-IL-5 therapy; therefore, current knowledge is presented to provide a reference point for the study of less-described diseases such as atopic dermatitis, chronic rhinosinusitis, chronic spontaneous urticaria, and its association with both IL-5 and anti-IL-5 treatment options. We then review the current literature on these diseases, explain where appropriate potential reasons why anti-IL-5 treatments are ineffective, and then point out possible future directions for further research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Exposure to Volatile Organic Compounds May Contribute to Atopic Dermatitis in Adults.
- Author
-
Tang, Kuo-Tung, Chen, Yu-Sin, Lee, Mey-Fann, Chen, Tzu-Ting, Lai, Chien-Chen, Lin, Chi-Chien, and Chen, Yi-Hsing
- Subjects
VOLATILE organic compounds ,AIR pollutants ,ATOPIC dermatitis ,ALLERGIES ,AIR pollution - Abstract
Background: Volatile organic compounds (VOC) are major indoor air pollutants. Previous studies reported an association between VOC exposure and allergic diseases. Here, we aimed to explore the relationship between VOC exposure and atopic dermatitis (AD) in adults. Methods: We prospectively enrolled 31 adult AD patients and 11 healthy subjects as controls. Urine metabolite levels of VOCs, including 1.3-butadiene, acrylamide, benzene, toluene, and xylene, were all determined with liquid chromatography–mass spectrometry. The relationship between AD and log-transformed urine levels of VOC metabolites were examined using a multivariate linear regression model adjusted for age and sex. We also treated mouse bone marrow-derived cells (BMMCs) with 1,3-butadiene and toluene and measured the release of β-hexosaminidase. Results: Our results demonstrated that creatinine-corrected urine levels of N-Acetyl-S- (3,4-dihydroxybutyl)-L-cysteine (DHBMA), N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (GAMA), and N-Acetyl-S-(benzyl)-L-cysteine (BMA) were all elevated in AD patients compared with controls. In a multivariate linear regression model, creatinine-corrected urine levels of BMA (a toluene metabolite) and DHBMA (a 1,3-butadiene metabolite) appeared elevated in AD patients, although statistical significance was not reached after correction for multiple comparisons. In addition, 1,3-butadiene and toluene could stimulate BMMCs to degranulate as much as compound 48/80. Conclusions: Some VOCs, such as 1,3-butadiene and toluene, might be associated with AD pathogenesis in adults. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Parental Attitudes and Practices regarding Atopic Dermatitis: A Cross-Sectional Study among a Thai Population.
- Author
-
Nummak, Phurithat, Techasatian, Leelawadee, Uppala, Rattapon, Sitthikarnkha, Phanthila, Saengnipanthkul, Suchaorn, and Sirikarn, Prapassara
- Subjects
EDUCATION of parents ,ATOPIC dermatitis ,CROSS-sectional method ,PEARSON correlation (Statistics) ,HEALTH attitudes ,RESEARCH funding ,ACADEMIC medical centers ,T-test (Statistics) ,DUST ,MALNUTRITION ,MULTIPLE regression analysis ,QUESTIONNAIRES ,FISHER exact test ,PARENT attitudes ,DESCRIPTIVE statistics ,CHI-squared test ,ALLERGIES ,PEDIATRICS ,ODDS ratio ,ENVIRONMENTAL exposure ,FOOD habits ,CONFIDENCE intervals ,DATA analysis software - Abstract
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder common in children. Successful pediatric AD therapy requires parental assistance. Thus, evaluating parental knowledge, attitudes, and behaviors regarding childhood AD may lead to more educational recommendations to help children control AD in the future. This study examined parents' knowledge, attitudes, and conduct concerning AD in families with and without children with AD. Method: The Pediatric Department, Faculty of Medicine, Khon Kaen University, Thailand, conducted a cross-sectional study from June to December 2023. Parents of children who visited the dermatology clinic with or without AD were asked to complete a Google form questionnaire. Results: A total of 372 parents answered a questionnaire about AD pathophysiology, knowledge, attitudes, and practices. The participants were 293 (78.8%) female participants and 79 (21.2%) male participants. The average age was 29.79 (SD 4.91). Most parents (319, 85.8%) did not work in the medical field, and more than half (228 instances, 61.29%) had children diagnosed with AD. Conclusions: Parents of children with AD understood AD causes and triggers better than parents of children without AD. But, "exposure to furry toys" that may contain dust and allergies and "infection" that may cause AD flare-ups were the most common triggers, regardless of the group. Appropriate information should be supplied because both the parents of children with AD and those of children without AD reported immediate food avoidance without confirmatory testing, which might lead to malnutrition. Clinicians and families handling patients with AD require further education. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. The Association between Migration and Prevalence of Allergic Diseases: A Systematic Review and Meta-Analysis.
- Author
-
Wong, Qi Yi Ambrose and Chew, Fook Tim
- Subjects
- *
ALLERGIES , *DISEASE prevalence , *ALLERGIC rhinitis , *ATOPIC dermatitis , *COUNTRY of origin (Immigrants) , *WHEEZE - Abstract
Allergic diseases remain of concern due to their increasing prevalence worldwide. Intrinsic and environmental risk factors have been implicated in the pathogenesis of allergic disease. Among the possible risk factors, migration has been associated with the manifestation of allergic diseases. We aimed to consolidate the existing evidence, review the hypotheses for the relationship between environmental factors and allergic disease, and provide a direction for future work.Introduction: This systematic review and meta-analysis complied with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The Web of Science database was searched in September 2023 to retrieve publications investigating the relationship between allergic rhinitis (AR), atopic dermatitis (AD), or asthma and the following factors: (i) migrant status (i.e., migrants vs. natives) or (ii) duration since migration among migrants. Risk of bias was assessed using the JBI critical appraisal tool. Details and findings from the included studies were also summarized and meta-analyses were conducted where appropriate.Methods: Fifty studies encompassing an estimated 3,755,248 individuals were reviewed. Articles investigated asthma (Results: n = 46), AR (n = 16), and AD (n = 14). A variety of migration-related factors were also studied: movement of individuals across regions (n = 40), duration since immigration (n = 12), age at immigration (n = 9), and acculturation (n = 2). Migration status was not significantly associated with AD (pooled odds ratio [pOR] = 0.68, 95% confidence interval (CI) = 0.31, 1.49). Although AR prevalence was lower among immigrants than natives (pOR = 0.58, 95% CI = 0.45, 0.74), immigrants who had resided at least 10 years in the destination country had a higher risk of AR than immigrants with a duration of residence of less than 10 years (pOR = 8.36, 95% CI = 4.15, 16.81). Being an immigrant was also associated with a decreased risk of asthma (pOR = 0.56, 95% CI = 0.44, 0.72). Among immigrants, residing in the host country for at least 10 years was associated with increased asthma manifestation (pOR = 1.85, 95% CI = 1.25, 2.73). Immigrants who migrated aged 5 and below did not exhibit a significantly higher likelihood of asthma than migrants who immigrated older than 5 years (pOR = 1.01, 95% CI = 0.68, 1.50). This review was limited by the primarily cross-sectional nature of the included studies. Objective diagnoses of allergic disease, such as using the spirometry of bronchodilator reversibility test for asthma rather than questionnaire responses, could add to the reliability of the outcomes. Furthermore, immigrant groups were mostly nonspecific, with little distinction between their country of origin. Overall, migration appears to be a protective factor for allergic diseases, but the protection subsides over time and the prevalence of allergic diseases among the immigrant group approaches that of the host population. [ABSTRACT FROM AUTHOR]Conclusion: - Published
- 2024
- Full Text
- View/download PDF
21. Prenatal Factors in the Development of Allergic Diseases.
- Author
-
Grijincu, Manuela, Buzan, Maria-Roxana, Zbîrcea, Lauriana-Eunice, Păunescu, Virgil, and Panaitescu, Carmen
- Subjects
- *
ALLERGIES , *FETAL development , *IMMUNOGLOBULIN E , *CORD blood , *B cells , *CHOLECALCIFEROL , *ATOPIC dermatitis , *FETUS - Abstract
Allergic diseases are showing increasing prevalence in Western societies. They are characterized by a heightened reactivity towards otherwise harmless environmental stimuli. Allergic diseases showing a wide range of severity of symptoms have a significant impact on the quality of life of affected individuals. This study aims to highlight the mechanisms that induce these reactions, how they progress, and which prenatal factors influence their development. Most frequently, the reaction is mediated by immunoglobulin E (IgE) produced by B cells, which binds to the surface of mast cells and basophils and triggers an inflammatory response. The antibody response is triggered by a shift in T-cell immune response. The symptoms often start in early childhood with eczema or atopic dermatitis and progress to allergic asthma in adolescence. An important determinant of allergic diseases seems to be parental, especially maternal history of allergy. Around 30% of children of allergic mothers develop allergic sensitization in childhood. Genes involved in the regulation of the epithelial barrier function and the T-cell response were found to affect the predisposition to developing allergic disorders. Cord blood IgE was found to be a promising predictor of allergic disease development. Fetal B cells produce IgE starting at the 20th gestation week. These fetal B cells could be sensitized together with mast cells by maternal IgE and IgE–allergen complexes crossing the placental barrier via the low-affinity IgE receptor. Various factors were found to facilitate these sensitizations, including pesticides, drugs, exposure to cigarette smoke and maternal uncontrolled asthma. Prenatal exposure to microbial infections and maternal IgG appeared to play a role in the regulation of T-cell response, indicating a protective effect against allergy development. Additional preventive factors were dietary intake of vitamin D and omega 3 fatty acids as well as decreased maternal IgE levels. The effect of exposure to food allergens during pregnancy was inconclusive, with studies having found both sensitizing and protective effects. In conclusion, prenatal factors including genetics, epigenetics and fetal environmental factors have an important role in the development of allergic disorders in later life. Children with a genetic predisposition are at risk when exposed to cigarette smoke as well as increased maternal IgE in the prenatal period. Maternal diet during pregnancy and immunization against certain allergens could help in the prevention of allergy in predisposed children. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. A Case of Refractory Vernal Keratoconjunctivitis Showing Improvement after the Administration of Upadacitinib for the Treatment of Atopic Dermatitis.
- Author
-
Mima, Yoshihito, Tsutsumi, Eri, Ohtsuka, Tsutomu, Ebato, Ippei, Nakata, Yukihiro, Kubota, Taro, and Norimatsu, Yuta
- Subjects
- *
ATOPIC dermatitis , *ALLERGIC rhinitis , *ALLERGIES , *EYE drops , *JAPANESE women , *AUTOIMMUNE diseases , *ALLERGIC conjunctivitis - Abstract
Vernal keratoconjunctivitis is a persistent allergic ocular disease predominantly mediated by the T-helper 2 lymphocyte-associated immune response. The standard therapeutic approaches for vernal keratoconjunctivitis include topical corticosteroids and immunosuppressive eye drops. However, managing vernal keratoconjunctivitis with only topical treatments becomes challenging during seasonally exacerbated periods. Systemic treatments such as oral corticosteroids or cyclosporine may be alternative options. Recently, dupilumab's efficacy in refractory vernal keratoconjunctivitis treatment has been documented. Here, we report a case of refractory vernal keratoconjunctivitis coexisting with atopic dermatitis that rapidly improved after upadacitinib administration. An 18-year-old Japanese woman presented with atopic dermatitis, vernal keratoconjunctivitis, and hay fever. In winter, the patient experienced widespread erythema and escalated itching, leading to significant discomfort and insomnia. Owing to the difficulty in maintaining her current regimen, upadacitinib (15 mg), a Janus kinase inhibitor was initiated. After upadacitinib administration, the treatment-resistant vernal keratoconjunctivitis and erythema improved. Upadacitinib is beneficial in severe cases of atopic dermatitis. Consequently, in our case, upadacitinib may offer therapeutic benefits for refractory vernal conjunctivitis by improving the T-helper 1/2 type immune response, autoimmunity, and oxidative stress. To our knowledge, this is the first report suggesting the potential utility of upadacitinib in managing severe vernal conjunctivitis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Predicting the daily number of patients for allergic diseases using PM10 concentration based on spatiotemporal graph convolutional networks.
- Author
-
Jeon, Hyeon-Ju, Jeon, Hyeon-Jin, and Jeon, Seung Ho
- Subjects
- *
ALLERGIES , *ALLERGIC rhinitis , *NATIONAL health insurance , *ATOPIC dermatitis , *AIR pollution - Abstract
Air pollution causes and exacerbates allergic diseases including asthma, allergic rhinitis, and atopic dermatitis. Precise prediction of the number of patients afflicted with these diseases and analysis of the environmental conditions that contribute to disease outbreaks play crucial roles in the effective management of hospital services. Therefore, this study aims to predict the daily number of patients with these allergic diseases and determine the impact of particulate matter (PM10) on each disease. To analyze the spatiotemporal correlations between allergic diseases (asthma, atopic dermatitis, and allergic rhinitis) and PM10 concentrations, we propose a multi-variable spatiotemporal graph convolutional network (MST-GCN)-based disease prediction model. Data on the number of patients were collected from the National Health Insurance Service from January 2013 to December 2017, and the PM10 data were collected from Airkorea during the same period. As a result, the proposed disease prediction model showed higher performance (R2 0.87) than the other deep-learning baseline methods. The synergic effect of spatial and temporal analyses improved the prediction performance of the number of patients. The prediction accuracies for allergic rhinitis, asthma, and atopic dermatitis achieved R2 scores of 0.96, 0.92, and 0.86, respectively. In the ablation study of environmental factors, PM10 improved the prediction accuracy by 10.13%, based on the R2 score. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Dietary Polyphenols, Plant Metabolites, and Allergic Disorders: A Comprehensive Review.
- Author
-
Farhan, Mohd, Rizvi, Asim, Aatif, Mohammad, Muteeb, Ghazala, Khan, Kimy, and Siddiqui, Farhan Asif
- Subjects
- *
PLANT metabolites , *POLYPHENOLS , *RESVERATROL , *ALLERGIC rhinitis , *ALLERGIES , *PLANT polyphenols , *DIETARY patterns , *QUERCETIN - Abstract
Given the ongoing rise in the occurrence of allergic disorders, alterations in dietary patterns have been proposed as a possible factor contributing to the emergence and progression of these conditions. Currently, there is a significant focus on the development of dietary therapies that utilize natural compounds possessing anti-allergy properties. Dietary polyphenols and plant metabolites have been intensively researched due to their well-documented anti-inflammatory, antioxidant, and immunomodulatory characteristics, making them one of the most prominent natural bioactive chemicals. This study seeks to discuss the in-depth mechanisms by which these molecules may exert anti-allergic effects, namely through their capacity to diminish the allergenicity of proteins, modulate immune responses, and modify the composition of the gut microbiota. However, further investigation is required to fully understand these effects. This paper examines the existing evidence from experimental and clinical studies that supports the idea that different polyphenols, such as catechins, resveratrol, curcumin, quercetin, and others, can reduce allergic inflammation, relieve symptoms of food allergy, asthma, atopic dermatitis, and allergic rhinitis, and prevent the progression of the allergic immune response. In summary, dietary polyphenols and plant metabolites possess significant anti-allergic properties and can be utilized for developing both preventative and therapeutic strategies for targeting allergic conditions. The paper also discusses the constraints in investigating and broad usage of polyphenols, as well as potential avenues for future research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases.
- Author
-
Berni Canani, Roberto, Caminati, Marco, Carucci, Laura, and Eguiluz‐Gracia, Ibon
- Subjects
- *
ALLERGIES , *EOSINOPHILIC esophagitis , *ALLERGIC rhinitis , *ATOPIC dermatitis , *FOOD allergy , *ALLERGIC conjunctivitis , *VOCAL cord dysfunction - Abstract
The epithelial barriers of the skin, gut, and respiratory tract are critical interfaces between the environment and the host, and they orchestrate both homeostatic and pathogenic immune responses. The mechanisms underlying epithelial barrier dysfunction in allergic and inflammatory conditions, such as atopic dermatitis, food allergy, eosinophilic oesophagitis, allergic rhinitis, chronic rhinosinusitis, and asthma, are complex and influenced by the exposome, microbiome, individual genetics, and epigenetics. Here, we review the role of the epithelial barriers of the skin, digestive tract, and airways in maintaining homeostasis, how they influence the occurrence and progression of allergic and inflammatory conditions, how current treatments target the epithelium to improve symptoms of these disorders, and what the unmet needs are in the identification and treatment of epithelial disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Six‐year trend of subsequent allergic diseases following Kawasaki disease and its clinical implications: A population‐based matched cohort study of 34,712 patients.
- Author
-
Kim, Dongeon, Shin, Ji Seong, Kim, Sin Young, and Kim, Jihye
- Subjects
- *
MUCOCUTANEOUS lymph node syndrome , *ALLERGIES , *ALLERGIC rhinitis , *ATOPIC dermatitis , *NATIONAL health insurance , *COHORT analysis - Abstract
Background: It has been suggested that allergic diseases may increase after Kawasaki disease (KD). We aimed to analyze the temporal patterns of allergic disease incidence after KD. Methods: A nationwide population‐based matched cohort study was conducted using data from the Korean National Health Insurance claims database. Patients aged <5 years diagnosed with KD and their 1:3 propensity score‐matched controls were included. Three cohorts were established: Cohort A, patients with allergies; Cohort B, patients without allergies; and Cohort C, patients without allergies, but excluding patients with birth history and underlying medical conditions. Cumulative incidence rates (%) and associated hospital visits for allergic rhinitis, atopic dermatitis, urticaria, and asthma were compared between the cases and controls during the 6‐year follow‐up period. Results: The study population comprised 8678 patients diagnosed with KD and 26,034 controls. In Cohort A, although initially, there were intergroup differences in the number of hospital visits for certain allergic diseases, these differences were inconsistent and varied depending on the type of allergic disease. Over time, the differences narrowed, and by the sixth year, the gap had decreased significantly. In Cohorts B and C, the initial incidence rates of the four allergic diseases and associated hospital visits were lower in patients with KD as compared to controls. However, with a faster rate of increase, the incidence rates and number of hospital visits eventually surpassed those of the controls. Conclusions: The pattern of delayed increase in cumulative incidence rates and hospital visits for allergic diseases after KD suggests the possibility of a shared genetic or immunologic susceptibility between KD and allergic diseases, which becomes evident over time, rather than a direct influence of KD resulting in allergic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. 宫内高血糖对新生儿炎症因子水平及婴儿 过敏性疾病发生的影响.
- Author
-
陈晓玲, 黄向贵, 周泳宜, 罗立荣, and 黄为民
- Subjects
- *
CORD blood , *INFANT diseases , *ALLERGIES , *ATOPIC dermatitis , *DISEASE incidence , *HYPERGLYCEMIA - Abstract
Objective To evaluate the effect of intrauterine hyperglycemia exposure on inflammatory cytokine levels in neonatal umbilical cord blood and the incidence of allergic diseases in infants. Methods 112 pregnant women and their infants were enrolled. According to the glucose levels during pregnancy, all women were divided into the intrauterine hyperglycemia exposure (n = 55) and non-intrauterine hyperglycemia exposure groups (n = 57). The levels of inflammatory cytokines in the umbilical cord blood were compared between two groups. During 1-year follow-up, the incidence of allergic diseases such as atopic dermatitis and wheezing in infants was compared between two groups. The impact of intrauterine hyperglycemia on neonatal immunity and infant allergic diseases was evaluated. Results There were no significant differences in the levels of IL-1β, IL-2, IL-6, IL-8, IL-10, IL12 and TNF-α between two groups (all P > 0.05). In the intrauterine hyperglycemia exposure group, the IL-4 level in the umbilical cord blood was (30.180±8.648) pg/mL, significantly higher than (22.500±10.100) in the non-intrauterine hyperglycemia exposure group (P < 0.05). In the intrauterine hyperglycemia exposure group, the incidence of allergic diseases was 34.7%, higher compared with 24.0% in the non-intrauterine hyperglycemia exposure group during 1-year follow-up. However, there was no significant difference between two groups (P > 0.05). Conclusion Intrauterine hyperglycemia exposure exerts certain effect on the IL-4 level in the neonatal cord blood, which may provide evidence for early intervention of allergic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Identification of plasma protein markers of allergic disease risk: a mendelian randomization approach to proteomic analysis.
- Author
-
Cao, Ziqin, Li, Qiangxiang, Li, Yajia, and Wu, Jianhuang
- Subjects
- *
BLOOD proteins , *PROTEOMICS , *ALLERGIES , *ALLERGIC rhinitis , *ATOPIC dermatitis , *PROTEIN-protein interactions , *ANDROGEN receptors - Abstract
Background: While numerous allergy-related biomarkers and targeted treatment strategies have been developed and employed, there are still signifcant limitations and challenges in the early diagnosis and targeted treatment for allegic diseases. Our study aims to identify circulating proteins causally associated with allergic disease-related traits through Mendelian randomization (MR)-based analytical framework. Methods: Large-scale cis-MR was employed to estimate the effects of thousands of plasma proteins on five main allergic diseases. Additional analyses including MR Steiger analyzing and Bayesian colocalisation, were performed to test the robustness of the associations; These findings were further validated utilizing meta-analytical methods in the replication analysis. Both proteome- and transcriptome-wide association studies approach was applied, and then, a protein-protein interaction was conducted to examine the interplay between the identified proteins and the targets of existing medications. Results: Eleven plasma proteins were identified with links to atopic asthma (AA), atopic dermatitis (AD), and allergic rhinitis (AR). Subsequently, these proteins were classified into four distinct target groups, with a focus on tier 1 and 2 targets due to their higher potential to become drug targets. MR analysis and extra validation revealed STAT6 and TNFRSF6B to be Tier 1 and IL1RL2 and IL6R to be Tier 2 proteins with the potential for AA treatment. Two Tier 1 proteins, CRAT and TNFRSF6B, and five Tier 2 proteins, ERBB3, IL6R, MMP12, ICAM1, and IL1RL2, were linked to AD, and three Tier 2 proteins, MANF, STAT6, and TNFSF8, to AR. Conclusion: Eleven Tier 1 and 2 protein targets that are promising drug target candidates were identified for AA, AD, and AR, which influence the development of allergic diseases and expose new diagnostic and therapeutic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. The risk of open angle glaucoma in young adults with allergic diseases: a Nationwide cohort study.
- Author
-
Han, Kyungdo, Jung, Jin-Hyung, Jung, Younhea, Ohn, Kyoung, and Moon, Jung Il
- Subjects
- *
OPEN-angle glaucoma , *ALLERGIES , *YOUNG adults , *ALLERGIC rhinitis , *ATOPIC dermatitis , *EYE drops - Abstract
This study investigated the potential associations between allergic diseases (asthma, allergic rhinitis, and atopic dermatitis) and the development of primary open-angle glaucoma. We utilized authorized data from the Korean National Health Information Database (KNHID), which provides comprehensive medical claims data and information from the National Health Screening Program. We compared the baseline characteristics of subjects with and without allergic diseases and calculated the incidence and risk of glaucoma development. Cox proportional hazard regression analysis was used to determine the risk of glaucoma development in subjects with allergic diseases. A total of 171,129 subjects aged 20–39 with or without allergic diseases who underwent a general health examination between 2009 and 2015 were included. Subjects with allergic diseases exhibited a higher incidence of glaucoma compared to the control group. The hazard ratio (HR) of glaucoma onset was 1.49 and 1.39 in subjects with at least one allergic disease before and after adjusting for potential confounding factors, respectively. Among allergic diseases, atopic dermatitis showed the highest risk for glaucoma development (aHR 1.73) after adjusting for confounders. Allergic rhinitis showed an increased risk for incident glaucoma after adjustment (aHR 1.38). Asthma showed the lowest but still increased risk for glaucoma (aHR 1.22). The associations were consistent in all subgroup analyses stratified by sex, smoking, drinking, exercise, diabetes, hypertension, dyslipidemia, or history of steroid. In conclusion, allergic diseases are associated with increased risk of glaucoma development. Among allergic diseases, atopic dermatitis showed the highest risk for glaucoma development followed by allergic rhinitis and asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Staphylococcal superantigen‐like protein 3 triggers murine mast cell adhesion by binding to CD43 and augments mast cell activation.
- Author
-
Kawano, Sae, Noda, Chisaki, Itoh, Saotomo, Urabe, Ayaka, Fujii, Chifumi, Ogawa, Isamu, Suzuki, Ryo, and Hida, Shigeaki
- Subjects
- *
CELL adhesion , *MAST cells , *FIBRONECTINS , *TOLL-like receptor agonists , *TRYPTASE , *ATOPIC dermatitis , *ALLERGIES , *STAPHYLOCOCCUS aureus - Abstract
Staphylococcus aureus is a noteworthy pathogen in allergic diseases, as four staphylococcal exotoxins activate mast cells, a significant contributor to inflammation, in an IgE‐independent manner. Although the adhesion of mast cells is an essential process for their immune responses, only a small number of exotoxins have been reported to affect the process. Here, we demonstrated that staphylococcal superantigen‐like (SSL) 3, previously identified as a toll‐like receptor 2 agonist, induced the adhesion of murine bone marrow‐derived mast cells to culture substratum. SSL3‐induced adhesion was mediated by fibronectin in an Arg‐Gly‐Asp (RGD) sequence‐dependent manner, suggesting the integrins were involved in the process. Additionally, SSL3 was found to bind to an anti‐adhesive surface protein CD43. SSL3 induced the adhesion of HEK293 cells expressing exogenous CD43, suggesting that CD43 is the target molecule for adhesion induced by SSL3. Evaluation of SSL3‐derived mutants showed that the C‐terminal region (253–326), specifically T285 and H307, are necessary to induce adhesion. SSL3 augmented the IL‐13 production of mast cells in response to immunocomplex and SSL12. These findings reveal a novel function of SSL3, triggering cell adhesion and enhancing mast cell activation. This study would clarify the correlation between S. aureus and allergic diseases such as atopic dermatitis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Editorial on the virtual issue "Food allergy".
- Author
-
Votto, Martina, Peters, Rachel, Riggioni, Carmen, and Eigenmann, Philippe
- Subjects
- *
FOOD allergy , *PEANUT allergy , *ECZEMA , *ATOPIC dermatitis , *ALLERGIES , *BEHAVIOR disorders , *DIETARY patterns - Abstract
This article discusses the topic of food allergies, which are adverse reactions to certain foods that involve the immune system. Food allergies can be classified into IgE-mediated forms and non-IgE-mediated forms, and they have a significant impact on patients' quality of life and healthcare systems. The article addresses various unmet needs in the field of pediatric food allergies, including the dietary management of food allergies, psychological support for children and parents, disease prevention strategies, environmental factors, and diagnostic biomarkers. The authors emphasize the importance of further research to improve our understanding of food allergies and address the gaps in knowledge. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
32. Atopy and allergic diseases among college students at a Saudi Public University.
- Author
-
Bin Abdulrahman, Khalid A., Alqasem, Abdulmlk A., Alsayyari, Abdulrahman M., Bintalib, Saud S., Khatlah, Abdullah N. B., Alshehri, Mohammed F., and Alasbali, Nawaf M.
- Subjects
- *
ATOPIC dermatitis , *MUSLIM students , *ALLERGIC rhinitis , *ALLERGIES , *ASTHMA - Abstract
Background: Despite its significant prevalence worldwide, atopy and allergic diseases continue to need more studies, with a need for published articles describing the prevalence of atopy and allergic diseases in Saudi society. The study aimed to determine the prevalence of atopic dermatitis diseases among college students at Imam Mohammad Ibn Saud Islamic University. Methods: The Cross‑sectional study was conducted in Saudi Arabia among college students at Imam Mohammed bin Saud Islamic University in Riyadh based on self‑report Asthma and Allergies questionnaires (ISSAC questionnaire, atopic dermatitis part). Results: Seven hundred ninety‑seven (797) students from 11 colleges participated in the study. About half (47.6%) aged between 21 and 24, and 73.7% were females. More than one‑third (34.8%) had atopic dermatitis during the last six months, while 30.7% of the participants reported having itchy rash in the past 12 months, and 33.8% were diagnosed with eczema in any life interval. Age is not one of the significant factors affecting the prevalence of atopic dermatitis. However, the prevalence of atopic dermatitis slightly increases with age (P = 0.062). Atopic dermatitis was significantly higher among female students (39.7%) than 21.0% among male students (P = 0.000). College level nor GPA had no significant impact on the prevalence of atopic dermatitis (P = 0.238 and 0.884, respectively). Conclusion: Imam Mohammad Ibn Saud Islamic University students have a high prevalence of atopic dermatitis, which may indicate a higher prevalence of allergens. Females and older participants were more liable to reported atopic dermatitis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. The Role of Regulatory T Cells in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2024.
- Author
-
Martín-Cruz, Leticia, Benito-Villalvilla, Cristina, Sirvent, Sofía, Angelina, Alba, and Palomares, Oscar
- Subjects
- *
REGULATORY T cells , *ALLERGIES , *ALLERGIC rhinitis , *FOOD allergy , *ATOPIC dermatitis - Abstract
Background: Allergy represents a major health problem of increasing prevalence worldwide with a high socioeconomic impact. Our knowledge on the molecular mechanisms underlying allergic diseases and their treatments has significantly improved over the last years. The generation of allergen-specific regulatory T cells (Tregs) is crucial in the induction of healthy immune responses to allergens, preventing the development and worsening of allergic diseases. Summary: In the last decades, intensive research has focused on the study of the molecular mechanisms involved in Treg development and Treg-mediated suppression. These mechanisms are essential for the induction of sustained tolerance by allergen-specific immunotherapy (AIT) after treatment discontinuation. Compelling experimental evidence demonstrated altered suppressive capacity of Tregs in patients suffering from allergic rhinitis, allergic asthma, food allergy, or atopic dermatitis, as well as the restoration of their numbers and functionality after successful AIT. Key Message: The better understanding of the molecular mechanisms involved in Treg generation during allergen tolerance induction might well contribute to the development of novel strategies for the prevention and treatment of allergic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Relation between Serum 25 Hydroxy Vitamin D Levels and Severity of Atopic Dermatitis.
- Author
-
Murshidi, Injy, Ghanem, Afaf, Shawky, Nagwa, and Abdel Shafy, Ahmed Said
- Subjects
- *
VITAMIN D , *ATOPIC dermatitis , *VITAMIN D deficiency , *FAT-soluble vitamins , *ECZEMA , *ALLERGIES , *SEASONAL variations of diseases - Abstract
Background & Aim: Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disorder. The ethiopathogenesis of AD is complicated, but is mainly due to a multifactorial interplay between the presence of a defective skin barrier, immunological dysregulation and environmental factors. Vitamin D is a fat-soluble vitamin synthesized in the skin. Recently, there have been several reports that low vitamin D plays a role in the pathogenesis of many conditions including AD. Adaptive and innate immune systems are both regulated by Vitamin D. Consequently, an obvious link between Vitamin D and allergic diseases was constantly a matter of investigation and research. Therefore, the aim of this study was to determine if there was a relationship between Vitamin D deficiency and the severity of Atopic Dermatitis. Methods: The study included 36 patients suffering from mild, moderate, and severe atopic dermatitis assessed according to SCORAD index and 36 apparently healthy subjects as a control group. The study was conducted in the Dermatology, Venereology and Andrology outpatients’ clinic at Zagazig University hospitals from November 2018 to April 2019 to avoid seasonal variations in Vitamin D levels. Results: Our study showed that 81.8% of the severe AD cases had deficient vitamin D levels compared to 23.1% and 50% among mild and moderate AD cases respectively, with a statistically significant difference among cases. Conclusion: Vitamin D deficiency is a contributing factor for the worsening of AD in the form of a high SCORAD index. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Ethanol Extract of Ampelopsis brevipedunculata Rhizomes Suppresses IgE-Mediated Mast Cell Activation and Anaphylaxis.
- Author
-
Park, Ji-Yeong, Kim, Min-Jong, Choi, Young-Ae, Lee, Seung Woong, Lee, Soyoung, Jang, Yong Hyun, and Kim, Sang-Hyun
- Subjects
- *
MAST cells , *ANAPHYLAXIS , *ORAL drug administration , *ATOPIC dermatitis , *ALLERGIES , *ETHANOL , *TUMOR necrosis factors , *INTRACELLULAR calcium - Abstract
More than 20% of the world's population suffers from allergic diseases, including allergic asthma, rhinitis, and atopic dermatitis that severely reduce the patient's quality of life. The treatment of allergy has been developed, but there are still unmet needs. Ampelopsis brevipedunculata (Maxim.) Trautv. is a traditional medicinal herb with beneficial bioactivities, such as antioxidant, anti-hypertension, anti-viral, anti-mutagenic, and skin and liver (anti-hepatotoxic) protective actions. However, its anti-allergic effect has not been addressed. This study designed to investigate the pharmacological effect of an ethanol extract of A. brevipedunculata rhizomes (ABE) on mast cell and anaphylaxis models. For in vivo studies, we used ovalbumin-induced active systemic anaphylaxis (ASA) and immunoglobulin (Ig) E-mediated passive cutaneous anaphylaxis (PCA) models. In ASA model, oral administration of ABE (1, 10, and 100 mg/kg) attenuated the anaphylactic responses, such as hypothermia, serum histamine, and IgE productions. In PCA model, ABE also suppressed the plasma extravasation and swelling. The underlying mechanisms of action were identified in various mast cell types. In vitro, ABE (10, 30, and 60 µg/mL) inhibited the release of essential allergic mediators, such as histamine and β-hexosaminidase, in a concentration-dependent manner. ABE prevented the rapid increase in intracellular calcium levels induced by the DNP-HSA challenge. In addition, ABE downregulated the tumor necrosis factor-α and interleukin-4 by suppressing the activation of nuclear factor-κB. Collectively, this study is the first to identify the anti-allergic effect of ABE, suggesting that ABE is a promising candidate for treating allergic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. A Rare Case of Eczema Herpeticum After Subcutaneous Immunotherapy.
- Author
-
TEPETAM, Fatma Merve, OZDEN, Seyma, YAKUT, Tugce, MERSIN, Selver Seda, and ORCEN, Cihan
- Subjects
- *
IMMUNOGLOBULIN analysis , *ATOPIC dermatitis , *COMBINATION drug therapy , *RARE diseases , *CLAVULANIC acid , *IMMUNOTHERAPY , *AMOXICILLIN , *ACYCLOVIR , *ALLERGIES , *SEVERITY of illness index , *TREATMENT effectiveness , *ALLERGIC rhinitis , *SEASONAL variations of diseases , *KAPOSI varicelliform eruption , *ANTIHISTAMINES , *ALLERGY desensitization , *DERMATOLOGISTS , *SUBCUTANEOUS injections , *SKIN tests , *MEDICAL referrals , *DRUG dosage , *THERAPEUTICS , *DRUG administration , *DIAGNOSIS , *DRUG therapy - Abstract
Eczema herpeticum (EH), also known as varicelliform eruption of Kaposi, is a herpes simplex virus infection that develops mainly in the setting of pre-existing chronic dermatoses such as atomic dermatitis, ichthyosis, seborrheic dermatitis, Darier's disease, pemphigus foliaceus, mycosis fungoides, and psoriasis, and is most commonly associated with atopic dermatitis. In this article, we describe an 18-year-old female patient with atopic dermatitis diagnosed with EH after subcutaneous allergen immunotherapy for allergic rhinitis and present this very rare side effect in the light of the current literature. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. The Association of Allergy and Systemic Lupus Erythematosus as a Single Disease and an Overlapping Syndrome compared to Control Group.
- Author
-
Nareswari, Kirana Pawitra, Werdiningsih, Yulyani, Pratiwi, Dewi, Aryani, Niken Dyah, and Matea, Ari
- Subjects
- *
ATOPIC dermatitis , *ALLERGIES , *ALLERGIC rhinitis , *SYSTEMIC lupus erythematosus , *SYNDROMES , *AUTOIMMUNE diseases - Abstract
Allergic diseases and systemic lupus erythematosus (SLE) sometimes are being connected since both of these diseases are affected by gene-environment processes. SLE can appear coexisting with other autoimmune diseases as an overlapping syndrome. This research was done to investigate the relation of allergic diseases and SLE as a single SLE or overlapping syndrome compared to control. We collected datas from 39 SLE only, 22 overlapping syndrome SLE, and 39 non SLE subjects who had filled an online Score for Allergic Rhinitis (SFAR) questionnaire. There are significant outcomes of the existance of allergic disease (p=.007), atopic dermatitis (p=.000) and total number of allergies (p=.016) in SLE patients. There is a correlation of the appearance of allergy in SLE as a single or coexisting with other autoimmune disease compared to control group. Atopic dermatitis and the more number of allergic diseases that the one have, play role in appearing SLE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Best practices for multimodal clinical data management and integration: An atopic dermatitis research case.
- Author
-
Ohta, Tazro, Hananoe, Ayaka, Fukushima-Nomura, Ayano, Ashizaki, Koichi, Sekita, Aiko, Seita, Jun, Kawakami, Eiryo, Sakurada, Kazuhiro, Amagai, Masayuki, Koseki, Haruhiko, and Kawasaki, Hiroshi
- Subjects
- *
DATA management , *DATA integration , *ATOPIC dermatitis , *BEST practices , *ALLERGIES - Abstract
In clinical research on multifactorial diseases such as atopic dermatitis, data-driven medical research has become more widely used as means to clarify diverse pathological conditions and to realize precision medicine. However, modern clinical data, characterized as large-scale, multimodal, and multi-center, causes difficulties in data integration and management, which limits productivity in clinical data science. We designed a generic data management flow to collect, cleanse, and integrate data to handle different types of data generated at multiple institutions by 10 types of clinical studies. We developed MeDIA (Medical Data Integration Assistant), a software to browse the data in an integrated manner and extract subsets for analysis. MeDIA integrates and visualizes data and information on research participants obtained from multiple studies. It then provides a sophisticated interface that supports data management and helps data scientists retrieve the data sets they need. Furthermore, the system promotes the use of unified terms such as identifiers or sampling dates to reduce the cost of pre-processing by data analysts. We also propose best practices in clinical data management flow, which we learned from the development and implementation of MeDIA. The MeDIA system solves the problem of multimodal clinical data integration, from complex text data such as medical records to big data such as omics data from a large number of patients. The system and the proposed best practices can be applied not only to allergic diseases but also to other diseases to promote data-driven medical research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Analysis on epidemiological characteristics and multiple diseases of allergic diseases in children born from 2017 to 2022 in Yichang city.
- Author
-
SUN Ming-wei, LIU Qin, WANG Qi-qi, LI Guo-xing, ZHANG Yan-li, and SUN Jin-fang
- Subjects
- *
ALLERGIES , *JUVENILE diseases , *ALLERGIC rhinitis , *ATOPIC dermatitis , *THERAPEUTICS - Abstract
Objective Based on the health big data platform of Yichang city, to analyze the characteristics of allergic diseases of children born in medical institutions from 2017 to 2022 in Yichang city, and to clarify the distribution of allergic diseases among children in Yichang city. Methods Statistical analysis was conducted based on the records of born children with allergic diseases in the outpatient clinic of urban comprehensive medical institutions from 2017 to 2022 in the big data cloud platform of Yichang city. Results The number of visits of male children was 68 707, more than that of female children, and the number of visits had been increasing since 2017. The highest number of hospital visits was 46 190 (37.86%) among children of 0-1 year old, of which the highest number of visits was 3 331 (13.74%) among children of two months. Atopic dermatitis/eczema and allergic rhinitis had a higher number of visits with 46 156 and 14 388 visits, respectively. The age of onset of atopic dermatitis was earlier, with the age of first consultation being 0.42 years, and the age of onset was earlier in males than in females. Atopic dermatitis/eczema and allergic rhinitis were the most common multimorbidities. Conclusion For children with atopic dermatitis/eczema and/or allergic rhinitis, the focus is on the development of concomitant diseases to further interrupt the allergic process and promote early detection, prevention and treatment of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK.
- Author
-
Oh, Jiyeon, Lee, Myeongcheol, Kim, Minji, Kim, Hyeon Jin, Lee, Seung Won, Rhee, Sang Youl, Koyanagi, Ai, Smith, Lee, Kim, Min Seo, Lee, Hayeon, Lee, Jinseok, and Yon, Dong Keon
- Subjects
ALLERGIES ,RHINITIS ,COVID-19 pandemic ,ALLERGIC rhinitis ,ATOPIC dermatitis ,FOOD allergy - Abstract
As mounting evidence suggests a higher incidence of adverse consequences, such as disruption of the immune system, among patients with a history of COVID-19, we aimed to investigate post-COVID-19 conditions on a comprehensive set of allergic diseases including asthma, allergic rhinitis, atopic dermatitis, and food allergy. We used nationwide claims-based cohorts in South Korea (K-CoV-N; n = 836,164; main cohort) and Japan (JMDC; n = 2,541,021; replication cohort A) and the UK Biobank cohort (UKB; n = 325,843; replication cohort B) after 1:5 propensity score matching. Among the 836,164 individuals in the main cohort (mean age, 50.25 years [SD, 13.86]; 372,914 [44.6%] women), 147,824 were infected with SARS-CoV-2 during the follow-up period (2020−2021). The risk of developing allergic diseases, beyond the first 30 days of diagnosis of COVID-19, significantly increased (HR, 1.20; 95% CI, 1.13−1.27), notably in asthma (HR, 2.25; 95% CI, 1.80−2.83) and allergic rhinitis (HR, 1.23; 95% CI, 1.15−1.32). This risk gradually decreased over time, but it persisted throughout the follow-up period (≥6 months). In addition, the risk increased with increasing severity of COVID-19. Notably, COVID-19 vaccination of at least two doses had a protective effect against subsequent allergic diseases (HR, 0.81; 95% CI, 0.68−0.96). Similar findings were reported in the replication cohorts A and B. Although the potential for misclassification of pre-existing allergic conditions as incident diseases remains a limitation, ethnic diversity for evidence of incident allergic diseases in post-COVID-19 condition has been validated by utilizing multinational and independent population-based cohorts. SARS-CoV-2 infection has been linked to various persistent or new-onset health consequences, including disruption of the immune system. Here, the authors investigate the risk of new-onset allergic diseases following SARS-CoV-2 infection using data from South Korea, Japan, and the UK. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Association between allergic diseases, generalized anxiety disorder, and depressive symptoms in South Korean adolescents: a secondary data analysis of the 2022 Korea Youth Risk Behavior Survey.
- Author
-
Lee, Jaeyoung and Park, So Yeon
- Subjects
MENTAL depression risk factors ,RISK assessment ,CROSS-sectional method ,ATOPIC dermatitis ,SECONDARY analysis ,BODY mass index ,HEALTH status indicators ,QUESTIONNAIRES ,HIGH school students ,MULTIPLE regression analysis ,RESIDENTIAL patterns ,ALLERGIES ,DESCRIPTIVE statistics ,CHI-squared test ,ECONOMIC status ,BODY image ,MIDDLE school students ,ODDS ratio ,RHINITIS ,FAMILY structure ,ACADEMIC achievement ,PSYCHOLOGICAL stress ,DATA analysis software ,CONFIDENCE intervals ,SOCIODEMOGRAPHIC factors ,SLEEP quality ,HOUSING ,GENERALIZED anxiety disorder ,ASTHMA ,DISEASE complications ,ADOLESCENCE - Abstract
Purpose: This study investigated the relationship between allergic diseases, general anxiety disorder, and depressive symptoms among Korean adolescents. Methods: A secondary analysis was conducted on the findings of the 18th Korea Youth Risk Behavior Survey (2022). The study included 51,850 adolescents and analyzed the relationships among allergic diseases, general anxiety disorder, and depressive symptoms using complex samples logistic regression analysis. Results: Among the Korean adolescents, 12.7% experienced general anxiety disorder, while 28.7% experienced depressive symptoms. The prevalence of allergic diseases was 5.7% for asthma, 36.3% for allergic rhinitis, and 22.2% for atopic dermatitis. General anxiety disorder was associated with asthma and allergic rhinitis but not atopic dermatitis. Depressive symptoms were associated asthma, allergic rhinitis, and atopic dermatitis. Conclusion: Examining the correlation among allergic diseases, general anxiety disorder, and depressive symptoms in adolescents underscores the need for implementing suitable strategies. Moreover, when addressing general anxiety disorder and depressive symptoms in adolescents, it becomes crucial to consider the presence of allergic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Postępowanie w chorobach alergicznych u dzieci w okresie pandemii wirusa SARS-CoV-2.
- Author
-
Baut, Marcin, Biela-Mazur, Jadwiga, Czyżewska-Dudek, Anna, and Kurzawa, Ryszard
- Subjects
PREVENTION of infectious disease transmission ,HEALTH literacy ,ALLERGENS ,ATOPIC dermatitis ,RISK assessment ,SKIN care ,ALLERGIES ,DISINFECTION & disinfectants ,ALLERGIC rhinitis ,SEASONAL variations of diseases ,ANTIHISTAMINES ,TELEMEDICINE ,INFECTIOUS disease transmission ,HEALTH facilities ,COVID-19 pandemic ,COVID-19 ,SOAP ,GLUCOCORTICOIDS ,DISEASE risk factors ,CHILDREN - Abstract
Copyright of Polish Journal of Allergology / Alergologia Polska is the property of Termedia Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
43. Higher levels of basal serum tryptase are associated with sensitization, FeNO, allergic morbidity, and lower control of allergic asthma in teenagers from the PARIS birth cohort.
- Author
-
Chantran, Yannick, Choi, Simone, Roda, Céline, Nicaise‐Roland, Pascale, Chaisemartin, Luc, Chollet‐Martin, Sylvie, Arock, Michel, Rancière, Fanny, and Momas, Isabelle
- Subjects
- *
THYMIC stromal lymphopoietin , *PASSIVE smoking , *ATOPIC dermatitis , *SYMPTOMS , *ALLERGIES , *MAST cell disease , *HOOKAHS - Abstract
This article discusses a study conducted on teenagers from the PARIS birth cohort to assess the association between basal serum tryptase (bST) levels and various allergy-related outcomes. The study found that higher bST levels were associated with sensitization, allergic morbidity, and lower control of allergic asthma. The results suggest that bST levels could be a potential tool for predicting and stratifying allergic phenotypes in early life. The study provides valuable insights into the relationship between bST levels and allergies in teenagers. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
44. Immediate‐type allergy to d‐limonene and anethole in toothpaste.
- Author
-
Hennighausen, Iris, Mühlenbein, Stefan, and Pfützner, Wolfgang
- Subjects
- *
TOOTHPASTE , *ALLERGIES , *ASTHMA , *ALLERGIC conjunctivitis , *ATOPIC dermatitis - Abstract
This article discusses a case report of an 8-year-old girl who experienced shortness of breath and an itchy nose when brushing her teeth with different brands of toothpaste. Skin prick tests and open patch tests revealed that she had an immediate-type allergy to an aroma mixture called Optamint®, which contained the substances d-limonene and anethole. These substances are commonly used as fragrance and flavoring agents in various products. The findings suggest that fragrance ingredients in toothpaste can cause immediate-type allergies, and it is important to identify the specific allergens in order to address the issue. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
45. Legends of allergy and immunology: Kenji Izuhara.
- Author
-
Nunomura, Satoshi, Sugita, Kazunari, and Arima, Kazuhiko
- Subjects
- *
PERIOSTIN , *ALLERGIES , *IMMUNOLOGY , *EMPLOYEE ownership , *MOLECULAR biology , *ATOPIC dermatitis - Abstract
Dr. Kenji Izuhara, a renowned figure in the field of allergy and immunology, has made significant contributions to our understanding of allergies and the immune system. His research on periostin, a protein involved in allergies, has deepened our knowledge in this area. Dr. Izuhara has also collaborated with other researchers to investigate the role of periostin in asthma, atopic dermatitis, and other chronic fibrotic diseases. In addition to his scientific contributions, Dr. Izuhara has been actively involved in teaching and promoting scientific exchanges internationally. His dedication and commitment to improving the well-being of patients affected by itch-related conditions are highly respected. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
46. Causal Association Between Allergic Diseases and Dementia: Evidence from Multivariate Mendelian Randomization Study.
- Author
-
Wang, YuanYing, Wang, ShiHao, Wu, JiaXin, Liu, XinLian, and Zhang, LuShun
- Subjects
- *
ALLERGIES , *DISEASE risk factors , *FILAGGRIN , *ALLERGIC rhinitis , *GENOME-wide association studies , *SINGLE nucleotide polymorphisms - Abstract
Background: The link between allergic diseases and dementia remains controversial, and the genetic causality of this link is unclear. Objective: This study investigated the causal relationship between allergic diseases and dementia using univariate and multivariate Mendelian randomization (MR) methods. Methods: We selected genome-wide association studies including 66,645 patients with allergic diseases and 12,281 patients with dementia, with statistical datasets derived from the FinnGen Consortium of European origin. After a rigorous screening process for single nucleotide polymorphisms to eliminate confounding effects, MR estimation was performed mainly using the inverse variance weighting method and the MR-Egger method. Sensitivity analyses were performed using Cochran's Q test, MR-PRESSO test, MR Pleiotropy residuals and leave-one-out analysis. Results: Univariate and multivariate MR together demonstrated a causal relationship between atopic dermatitis and reduced vascular dementia (VaD) risk (OR = 0.89, 95% CI: 0.81–0.99, p = 0.031; OR = 0.85, 95% CI: 0.76–0.95, p = 0.003). MVMR confirmed asthma was associated with a reduction in the risk of Alzheimer's disease (AD) (OR = 0.82, 95% CI: 0.71–0.94, p = 0.005) and may be associated with a reduction in the risk of VaD (OR = 0.80, 95% CI: 0.65–0.99, p = 0.042); allergic rhinitis may be causally associated with an increased risk of AD (OR = 1.16, 95% CI: 1.00–1.35, p = 0.046) and VaD (OR = 1.29, 95% CI: 1.03–1.62, p = 0.027). In sensitivity analyses, these findings were reliable. Conclusions: MR methods have only demonstrated that allergic rhinitis dementia is associated with an increased risk of developing dementia. Previously observed associations between other allergic diseases and dementia may be influenced by comorbidities and confounding factors rather than causality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Nine-Year Trend in the Prevalence of Allergic Diseases and Their Associated Factors in Young Adults.
- Author
-
Matsumoto, Munehiro, Kimura, Hirokazu, Shimizu, Kaoruko, Suzuki, Masaru, Asakura, Satoshi, Hashino, Satoshi, and Konno, Satoshi
- Subjects
- *
YOUNG adults , *ALLERGIES , *DISEASE prevalence , *DISEASE complications , *WHEEZE , *ALLERGIC rhinitis - Abstract
Introduction: Notably, few studies have evaluated the recent changes in the prevalence of allergic diseases in young adults. Studies examining the risk of allergy in two populations with similar social backgrounds, other than the region in which they live, are rare. Methods: First-year students from Hokkaido University were enrolled in this study between 2011 and 2019. A questionnaire survey was conducted to determine the annual prevalence of current wheeze, seasonal allergic rhinitis (SAR), and perennial allergic rhinitis (PAR) in nonsmoking young adults. Trends in the presence of these disease conditions were evaluated based on their hometowns (Hokkaido and outside Hokkaido separately) due to the low prevalence of cedar pollen allergies in Hokkaido. The association between these disease conditions and body mass index (BMI) was also assessed. Results: The prevalence of current wheeze and PAR food allergies did not change in both regions. SAR showed a significantly increasing trend; however, the prevalence of SAR was higher among those whose place of origin was not Hokkaido. Current wheeze was positively associated with obesity (p < 0.05), whereas the high prevalence of SAR was not associated with body weight. In contrast, a lean body type was significantly associated with a higher prevalence of PAR (p < 0.05). Discussion/Conclusion: The prevalence of current wheeze was stable and that of PAR has decreased over the past 9 years. However, the prevalence of SAR in Hokkaido has been increasing in Japanese young adults. A differential association between current wheeze and BMI was observed when comparing PAR and SAR. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Risk Factors for Severe Seafood Allergy Among Adults in an Urban City in Vietnam.
- Author
-
Trinh, Tu HK, Duong, Chi N, Pham, Tu HT, Au, Hao DT, Tran, Loc T, Nguyen, Cuong V, Nguyen, Han BG, Tran, Nguyen M, Phan, Quy Q, Le, Thu NA, and Nguyen, Nga
- Subjects
PEANUT allergy ,FOOD allergy ,ALLERGIES ,ATOPIC dermatitis ,SEAFOOD ,ADULTS - Abstract
Purpose: Increasing seafood consumption is associated with more frequent reports of food allergy. Little is known about seafood allergy (SFA) among adults in Vietnam. We investigated the characteristics of individuals with SFA and the risk factors for severe SFA. Patients and methods: A cross-sectional, web-based survey was conducted among individuals aged ≥ 18 years from universities in Ho Chi Minh City (Vietnam) between December 2021 and July 2022. The survey was based on a structured, validated questionnaire related to FA. Strict definitions of "convincing allergy" were used. Multivariate analysis was used to estimate the risk factors for severe SFA after adjusting for covariates. Data were analyzed using JASP (v.0.16.3) and SPSS (v.22.0). Results: Totally, 1038 out of 2137 (48.57%) individuals completed the questionnaire, of whom 285 (27.46%) had reported SFA. Convincing SFA accounted for 20.13% (209/1038) of the cases, with convincing shellfish allergy being more common than fish allergy. Participants with comorbid shellfish and fish allergy had higher prevalence of atopic dermatitis, peanut/nut allergy, other food allergy, and cutaneous and upper airway symptoms compared to participants with shellfish allergy (p < 0.05). The spectrum of reactive seafood was diverse and characterized by local species. The age of symptom onset was most commonly during late childhood and adolescence, with most reactions persisting into adulthood. A history of anaphylaxis, comorbid peanut, and tree nut allergy, and ≥ 3 allergens were associated with severe SFA. Conclusion: Features of causative, coexisting seafood allergy, and risk factors for severe SFA were demonstrated, which can provide a reference for future studies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Study of the effect of probiotics on the therapeutic effect obtained in the reduction of allergic symptoms in patients diagnosed with atopic dermatitis.
- Author
-
Banderowicz, Paula, Wierzbowska, Natalia, and Pawlik, Andrzej
- Subjects
THERAPEUTIC use of probiotics ,ATOPIC dermatitis ,BIFIDOBACTERIUM ,QUESTIONNAIRES ,EXANTHEMA ,ALLERGIES ,TREATMENT effectiveness ,DESCRIPTIVE statistics ,CHI-squared test ,TREATMENT duration ,SURVEYS ,RHINITIS ,LACTOBACILLUS ,DATA analysis software - Abstract
Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease posing a significant burden on healthcare resources and patients' quality of life. It is a complex disease with a wide spectrum of clinical presentations and combinations of symptoms. Atopic dermatitis affects up to 20% of children and up to 3% of adults. Recent data show that its prevalence is still increasing, especially in low-income countries. This study aimed to check whether the use of probiotic therapy affects the reduction of allergic symptoms in patients diagnosed with AD. Material and methods: Questionnaires of 70 respondents diagnosed with AD who took a probiotic for at least 5 days were analysed. To conduct the study, an anonymous, original survey was used in the form of a form created on Google Drive consisting of 19 questions with the possibility of answering both single and multiple choice and with the possibility of providing your own answer. Results: The most beneficial strains affecting the reduction of allergic symptoms are bacteria of the genus Lactobacillus. The average duration of use of probiotic therapy to reduce allergic symptoms is from 2 weeks to 3 months. Conclusions: The study showed that the implementation of probiotic therapy shortens the duration of therapy for AD and reduces allergic symptoms such as redness, itching of the skin and allergic rhinitis co-occurring in patients with AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Examining allergy related diseases in Africa: A scoping review protocol.
- Author
-
Lu, Max Yang, Shobnam, Nadia, Livinski, Alicia A., Saksena, Sarini, Salters, Dylan, Biete, Michelle, and Myles, Ian A.
- Subjects
- *
ALLERGIC rhinitis , *ATOPIC dermatitis , *FOOD allergy , *ALLERGIES , *RURAL geography ,DEVELOPING countries - Abstract
During recent decades, allergy related diseases have emerged as a growing area of concern in developing regions of the world, including Africa. Worldwide prevalence of allergic diseases has grown to an estimated 262 million for asthma, 400 million for allergic rhinitis (or hay fever), 171 million with atopic dermatitis (or eczema), and over 200 million for food allergy. In Africa, considerable variability exists in the data surrounding prevalence at the continent-wide, regional, and study site levels. Furthermore, research conducted in many rural areas and underdeveloped countries in Africa remains limited, and presently, little has been done to characterize and map the extremely heterogeneous body of literature which confounds research efforts. This scoping review will seek to identify studies examining the prevalence, management strategies, outcomes, and associated risk factors for allergy related diseases in Africa. The Joanna Briggs Institute's scoping review methods will be followed, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Review (PRISMA-ScR) was used for writing the protocol. Four databases (Embase, Global Health, PubMed, African Journals Online) will be searched for literature published from 2003 to 2023 in any language. Title and abstract screening and full-text screening will be completed by two independent reviewers using Covidence; conflicts resolved by a third reviewer. Data will be extracted using Covidence by two reviewers independently. To report the results, we will follow the PRISMA-ScR checklist and report descriptive statistics and a narrative summary. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.